Clinical Trials Browser

INDUSTRY × AML × Clear all

NCT06731699 2024-12-17

A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS

Phase 1 Recruiting

AML

NCT02418000 2019-03-20

A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

Phase 1/2 Terminated

27 enrolled 32 charts

AML